Dr. Laura Giusto, MD

Dr. Giusto practices at Clearway Surgery Center of National Harbor LLC in Oxon Hill, Maryland.

Dr. Giusto's NPI, 1205118296, was assigned on September 15, 2011. Dr. Giusto holds Maryland license D087064.

Dr. Giusto's primary practice is Clearway Surgery Center of National Harbor LLC, at 251 National Harbor Blvd, Oxon Hill, MD 20745 in Prince Georges County. The practice phone is (855) 527-7246.

Dr. Giusto's primary practice is Clearway Surgery Center of National Harbor LLC in Oxon Hill, Maryland. Dr. Giusto is also affiliated with WellSpan Gettysburg Hospital. The medical group on file is Chesapeake Urology Associates. Dmand AI also links Dr. Giusto to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Giusto practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Giusto's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Giusto's licenses on file in 2 states: Maryland and Pennsylvania.

CMS data shows 5,912 Medicare services from Dr. Giusto across 35 procedure codes in 2024, for 1,061 Medicare patients. Medicare paid $365,193 for them.

CMS counts 1,061 Medicare patients who saw Dr. Giusto in 2024. The largest group is 65 to 74, with 411 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Giusto's median patient age at 68, with 74% women.

In 2024, Dr. Giusto wrote 2,020 Medicare Part D claims for 659 patients. 73% of them were for generic drugs. CMS names the drug for 1,885 of them, across 23 drugs with 11 or more claims each, at $577,529 in total drug cost. In 2023, CMS named 1,603 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Giusto for performance year 2024, reported as part of a group. Dr. Giusto accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Giusto, published from 2018 to 2024. 2018 was the busiest year, with 2. The most frequent topics are Electric Stimulation Therapy, Urinary Bladder, Overactive and Botulinum Toxins, Type A. Dr. Giusto's most frequent co-authors are Patricia Martha Zahner, MD, Kevin D. Benson, MD and Kevin James Cline, MD.

CMS Open Payments shows 966 general payments to Dr. Giusto from 46 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Medtronic, Inc. paid the most, $196,167. It also lists 3 research payments totaling $3,900 from 2022 to 2025.